Staphylococcus Aureus Caught in Action at the Site of Infection
NCT04781569 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2021-06-03
Summary
This study is to obtain a comprehensive view of S. aureus adaptations in the infected human host and (i) to improve the understanding of the interface between antibiotic therapy, resistance development and virulence factor adaptation in S. aureus infected patients, and (ii) to adapt these findings into a more sustainable use of antimicrobials for therapy.
Conditions
- Staphylococcus (S.) Aureus Infection
Interventions
- OTHER
-
data collection
Health-related personal data such as year of birth, sex, Body Mass Index (BMI), infection classification, concomitant infections, comorbidities according to medical chart, standard diagnostic markers (CRP, blood differential plots, creatinine, ...), medication, treatment start, treatment end and discharge from hospital will be collected.
- DIAGNOSTIC_TEST
-
blood draw
2 blood drawing events (in total 22.5 ml) will be performed in the patient. 1 blood drawing events will be performed in the healthy proband.
- DIAGNOSTIC_TEST
-
nose swabs
2 nose swabs will be taken in the patient. 1 nose swab will be performed in the healthy proband.
- DIAGNOSTIC_TEST
-
Intraoperative tissue samples
Intraoperative tissue samples from the site of infection during surgery will be taken in the patient.
Sponsors & Collaborators
-
University Hospital, Basel, Switzerland
lead OTHER
Principal Investigators
-
Nina Khanna, PD Dr. med. · University Hospital, Basel, Switzerland
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2017-06-06
- Primary Completion
- 2020-11-23
- Completion
- 2020-11-23
Countries
- Switzerland
Study Locations
More Related Trials
-
Community-Assoc. S. Aureus Colonization and Recurrent Infection in Pts With Uncomplicated S. Aureus Skin Abscesses
NCT02690415 ·Status: COMPLETED
-
Evaluation of a Diagnostic Device for Detection of Nasal Staphylococcus Aureus
NCT00406549 ·Status: COMPLETED
-
Nasal Carrying by Staphylococcus Aureus ST398 Strains in Community and Hospital Settings
NCT03869255 ·Status: UNKNOWN
-
Ex Vivo Evaluation of Immunity Activation Face to S. Aureus Antigens and Adjuvants of a Vaccine Candidate in Cells From Haemodialysis Patients
NCT03643328 ·Status: COMPLETED ·Phase: NA
-
S. Aureus Screening and Decolonization
NCT02182115 ·Status: COMPLETED ·Phase: PHASE4
-
Human Immunity Against Staphylococcus Aureus Skin Infection
NCT02262819 ·Status: COMPLETED ·Phase: PHASE1
-
Study of Staphylococcus Aureus Colonization of the Posterior Nasal Cavity in Patients Undergoing Otorhinolaryngologic Surgery
NCT02595112 ·Status: COMPLETED ·Phase: NA
-
Study Evaluating Safety, Tolerability, and Efficacy of Intravenous AP-SA02 in Subjects With S. Aureus Bacteremia
NCT05184764 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Probability of Target Attainment With Standard Intermittent Bolus Administration of Cefazolin in Patients With Complicated Infections Caused by Staphylococcus Aureus
NCT04503252 ·Status: COMPLETED
-
Early Infectious Disease Consultations in Staphylococcus Aureus Bacteremia
NCT00622882 ·Status: UNKNOWN ·Phase: NA
-
Study of the Nasal Decolonisation of Staphylococcus Aureus (SA) and the Safety and Tolerability of XF-73 Nasal Gel in Healthy Subjects
NCT02282605 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Adjunctive Fosfomycin for Treatment of Staphylococcus Aureus Bacteraemia
NCT06695832 ·Status: ACTIVE_NOT_RECRUITING
-
Staphylococcus Aureus Carriers Students Nursing Oxacillin Resistant
NCT00518076 ·Status: UNKNOWN
-
Safety & Efficacy of True Human Antibody, 514G3, in Staphylococcus Aureus Bacteremia Hospitalized Subjects.
NCT02357966 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Virulence Determinants in S Aureus Bacteremia
NCT00319826 ·Status: COMPLETED
-
Study to Investigate the Safety, Tolerability, and Pharmacokinetics of DSTA4637S in Participants With Staphylococcus Aureus Bacteremia Receiving Standard-of-Care (SOC) Antibiotics
NCT03162250 ·Status: COMPLETED ·Phase: PHASE1
-
Prospective Study of Staphylococcus Aureus Clinical Isolates Versus Colonization: RNAs as Potential Biomarkers for Bloodstream Infections
NCT03833102 ·Status: COMPLETED
-
S. Aureus, Skin and Soft Tissue Infections
NCT02796742 ·Status: COMPLETED
-
Identification and Validation of Clinical Phenotypes in Staphylococcus Aureus Bacteremia and Their Association With Mortality and Development of Complicated Bacteremia
NCT06574399 ·Status: RECRUITING
-
A Novel Approach to Methicillin-resistant Staphylococcus Aureus (MRSA) Screening of Colonized Patients
NCT01234831 ·Status: COMPLETED ·Phase: NA
-
Prophylaxis With Intranasal Mupirocin for Prevention of S. Aureus Infections
NCT00156377 ·Status: COMPLETED ·Phase: PHASE4
-
Advanced Understanding of Staphylococcus Aureus Infections in Europe - Surgical Site Infections
NCT02935244 ·Status: COMPLETED
-
Antimicrobial Drug Use and Resistant Staphylococcus Aureus
NCT01075451 ·Status: COMPLETED
-
Staphylococcus Aureus Bacteremia: Impact of an Intervention Program in Improving the Clinical Management and Review of the Clinical and Molecular Epidemiology
NCT01971762 ·Status: COMPLETED
-
Study of the Efficacy and Safety of MEDI4893
NCT02296320 ·Status: COMPLETED ·Phase: PHASE2